Responsible oversight of human stem cell research: the California Institute for Regenerative Medicine's medical and ethical standards - PubMed (original) (raw)

Review

Responsible oversight of human stem cell research: the California Institute for Regenerative Medicine's medical and ethical standards

Geoffrey P Lomax et al. PLoS Med. 2007 May.

Abstract

California voters recently approved $3 billion over 10 years for public funding of stem cell research through the California Institute for Regenerative Medicine (CIRM). Geoffrey Lomax and colleagues discuss the principles that guided the CIRM regulations.

PubMed Disclaimer

Conflict of interest statement

Competing Interests: BL chairs the Stem Cell Research Oversight Committee at the University of California San Francisco.

Figures

CIRM developed comprehensive medical and ethical standards for stem cell research through a process involving extensive expert and public consultation.

(Credit: The Burnham Institute & CIRM)

Similar articles

• [Ethical justification for human stem cell research. The view of the German Central Ethics Committee for Stem Cell Research].
  Siep L; German Central Ethics Committee for Stem Cell Research. Siep L, et al. Bundesgesundheitsblatt Gesundheitsforschung Gesundheitsschutz. 2008 Sep;51(9):950-3. doi: 10.1007/s00103-008-0620-8. Bundesgesundheitsblatt Gesundheitsforschung Gesundheitsschutz. 2008. PMID: 18769901 German.
• [The criteria of high priority, adequacy of research in the animal and adult human models, and the absence of an alternative according to section 5 of the German Stem Cell Act: the ethical perspective].
  Beckmann JP. Beckmann JP. Bundesgesundheitsblatt Gesundheitsforschung Gesundheitsschutz. 2008 Sep;51(9):954-60. doi: 10.1007/s00103-008-0621-7. Bundesgesundheitsblatt Gesundheitsforschung Gesundheitsschutz. 2008. PMID: 18773177 German.
• [Report of activities of the Central Ethics Committee for Stem Cell Research. 6th report after implementation of the stem cell regulation for the period 1 December 2007 to 30 November 2008].
  [No authors listed] [No authors listed] Bundesgesundheitsblatt Gesundheitsforschung Gesundheitsschutz. 2009 Apr;52(4):469-73. doi: 10.1007/s00103-009-0834-4. Bundesgesundheitsblatt Gesundheitsforschung Gesundheitsschutz. 2009. PMID: 19290484 German. No abstract available.
• Proposition 71 and CIRM--assessing the return on investment.
  Longaker MT, Baker LC, Greely HT. Longaker MT, et al. Nat Biotechnol. 2007 May;25(5):513-21. doi: 10.1038/nbt0507-513. Nat Biotechnol. 2007. PMID: 17483831 Review.
• [Bioethics: problems and prospects within a research institute].
  Guidoni L. Guidoni L. Ann Ist Super Sanita. 2004;40(3):309-15. Ann Ist Super Sanita. 2004. PMID: 15637405 Review. Italian.

Cited by

• Immunosuppressive therapy mitigates immunological rejection of human embryonic stem cell xenografts.
  Swijnenburg RJ, Schrepfer S, Govaert JA, Cao F, Ransohoff K, Sheikh AY, Haddad M, Connolly AJ, Davis MM, Robbins RC, Wu JC. Swijnenburg RJ, et al. Proc Natl Acad Sci U S A. 2008 Sep 2;105(35):12991-6. doi: 10.1073/pnas.0805802105. Epub 2008 Aug 26. Proc Natl Acad Sci U S A. 2008. PMID: 18728188 Free PMC article.
• Towards a richer debate on tissue engineering: a consideration on the basis of NEST-ethics.
  Oerlemans AJ, van Hoek ME, van Leeuwen E, van der Burg S, Dekkers WJ. Oerlemans AJ, et al. Sci Eng Ethics. 2013 Sep;19(3):963-81. doi: 10.1007/s11948-012-9419-y. Epub 2012 Nov 15. Sci Eng Ethics. 2013. PMID: 23229374
• Short-term immunosuppression promotes engraftment of embryonic and induced pluripotent stem cells.
  Pearl JI, Lee AS, Leveson-Gower DB, Sun N, Ghosh Z, Lan F, Ransohoff J, Negrin RS, Davis MM, Wu JC. Pearl JI, et al. Cell Stem Cell. 2011 Mar 4;8(3):309-17. doi: 10.1016/j.stem.2011.01.012. Cell Stem Cell. 2011. PMID: 21362570 Free PMC article.
• Ethical issues in stem cell research.
  Lo B, Parham L. Lo B, et al. Endocr Rev. 2009 May;30(3):204-13. doi: 10.1210/er.2008-0031. Epub 2009 Apr 14. Endocr Rev. 2009. PMID: 19366754 Free PMC article. Review.
• Stem Cell Statute in Jordan: Leading the Way.
  Al-Tabba' A, Dajani R, Al-Hussaini M. Al-Tabba' A, et al. Front Genet. 2020 Jul 17;11:657. doi: 10.3389/fgene.2020.00657. eCollection 2020. Front Genet. 2020. PMID: 32765577 Free PMC article.

References

1. 1. National Academy of Sciences. Ethical considerations for research on housing-related health hazards involving children. Washington (D. C.): National Academy Press; 2005.
2. 1. Dawson L, Bateman-House AS, Mueller Agnew D, Bok H, Brock DW, et al. Safety issues in cell-based intervention trials. Fertil Steril. 2003;80:1077–1085. - PubMed
3. 1. Lo B, Chou V, Cedars M, Gates E, Taylor R, et al. Consent from donors for embryo and stem cell research. Science. 2003;301:921. - PubMed
4. 1. Greene M, Schill K, Takahashi S, Bateman-House A, Beauchamp T, et al. Ethics: Moral issues of human-non-human primate neural grafting. Science. 2005;309:385–386. - PubMed
5. 1. Magnus D, Cho MK. Issues in oocyte donation for stem cell research. Science. 2005;308:1747–1748. - PubMed

Publication types

MeSH terms

LinkOut - more resources

• Full Text Sources

  • Europe PubMed Central
  • PubMed Central
  • Public Library of Science